Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Piramal Pharma Price Movement Clarification

Piramal Pharma clarified that funding support from the Government of Ontario for its Aurora facility is not a material event requiring disclosure.

Key figures
Value₹0.17 Cr
Source

BSE filing, NSE: PPLPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Piramal Pharma Ltd: key numbers

Share price
₹232.80
Market cap
₹30,994 Cr
Revenue (annual)
₹8,869 Cr
Net profit (annual)
₹-325.9 Cr
P/E (TTM)
-148.4×Sector 46.1×
Promoter holding
34.80%+0.00% QoQ
FII holding
13.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Piramal Pharma Ltd

All →

Other price movement clarification announcements

All →